53
Research Trials
20
Peer-reviewed publications
16
Clinical Conditions
At CHEST 2025, held in Chicago, Illinois, Laurie Slovarp, PhD, CCC-SLP, professor at the University of Montana and certified speech pathologist, presented a poster on the development of a digital therapeutic designed to improve access to behavioral cough suppression therapy for patients with refractory chronic cough.
A large-scale trial examining the effect of azithromycin on the relationship between oesophageal function and cough as evaluated by Hyfe's cough monitoring technology in respiratory disease is feasible and acceptable to patients.
This study used Hyfe's wearable cough monitor during a 7-day run in, 28-day treatment, and 14-day follow-up period in patients with chronic bronchitis.
Periods of intense coughing (termed bouts, epochs or bursts) are particularly problematic for some coughers and may not be reflected by simply counting the number of coughs per day. This study explored how varying the definition of bouts yield different impressions of cough severity.
27.06.2022
We carried out a study evaluating potential uses of an AI-based cough detection system in northern Spain. Among enrolled participants there was a 71 year-old female with a history of smoking 20-40 cigarettes/day between ages 18to 36, and from age 67 to present. Past medical history revealed chronic non-productive cough, and several episodes of upper respiratory tract infections per year. She was enrolled in November 2020, when the AI system registered a mean cough frequency of 52 coughs/day. Following a quitting attempt in January 2021, she reported improvement in respiratory symptoms, which matched a reduction in cough frequency to 12 coughs/day.
This was sustained until April, when a smoking relapse increased cough frequency. Observing this contributed to her decision to stop smoking.
